# Brightside Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/brightside-health

- Industry: Healthcare Specialists
- Headquarters: San Francisco, US
- Website: www.brightside.com
- Total disclosed funding: $96M
- Latest round: Series C (Dec 12, 2023)
- Investors on record: 8

## About

Brightside Health, Inc. is a US-based company that provides online mental health care, specializing in the treatment of anxiety and depression through personalized, data-driven methodologies.Founded in 2017 and headquartered in San Francisco, US, Brightside Health, Inc. focuses on delivering accessible mental health solutions. The company was established by Brad Kittredge and Jeremy Barth, who have prior experience in the healthcare industry. As of December 2023, Brightside Health raised USD 33.01 mn in Series C funding led by Section 32, with participation from several other investors, bringing the total amount raised to USD 33.01 mn and valuing the company at USD 257.22 mn.Brightside Health specializes in providing online mental health care, focusing on personalized treatment plans for anxiety and depression. Utilizing a comprehensive virtual platform, the company combines cognitive and behavioral therapy with independent skill practice, addressing a variety of mental health issues. Brightside Health serves clients aged 13 and older across the United States, offering targeted support for challenges like self-esteem and academic stress.Brightside Health’s revenue model is based on subscription services, allowing clients to engage with personalized treatment plans through a free assessment process. Revenue is derived from individual therapy sessions and psychiatric consultations, with various payment options, including insurance, to enhance affordability and accessibility for clients seeking ongoing mental health support.In December 2023, Brightside Health, Inc. raised USD 33.01 mn in Series C funding to support its strategy for growth. The company plans to expand into new markets with a focus on enhancing its product offerings, utilizing the recent funding to bolster these initiatives.

## Funding rounds

- Series C, Dec 12, 2023, $33M — Mousse Partners, Triventures, ACME Capital, Section 32, Kennedy Lewis Investment Management, Time BioVentures
- Series B, Nov 23, 2021, $46M — Mousse Partners, Bullpen Capital, Triventures, ACME Capital, Trousdale Ventures
- Series A, Feb 8, 2021, $17M — Bullpen Capital, Triventures, ACME Capital

## Investors

- Bullpen Capital (https://capitalatlas.ai/funds/bullpen-capital) — Series A, Series B
- Triventures (https://capitalatlas.ai/funds/triventures) — Series A, Series B, Series C
- ACME Capital (https://capitalatlas.ai/funds/acme-capital) — Series A, Series B, Series C
- Mousse Partners — Series B, Series C
- Trousdale Ventures (https://capitalatlas.ai/funds/trousdale-ventures) — Series B
- Section 32 (https://capitalatlas.ai/funds/section-32) — Series C
- Kennedy Lewis Investment Management — Series C
- Time BioVentures (https://capitalatlas.ai/funds/time-bioventures) — Series C